Genmab
GMAB
GMAB
204 hedge funds and large institutions have $1.3B invested in Genmab in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 83 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 211 → 204 (-7)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
18% less capital invested
Capital invested by funds: $1.58B → $1.3B (-$282M)
Holders
204
Holding in Top 10
1
Calls
$851K
Puts
$10K
Top Buyers
| 1 | +$13.8M | |
| 2 | +$12.3M | |
| 3 | +$10.5M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$10.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.64M |
Top Sellers
| 1 | -$26.2M | |
| 2 | -$19.5M | |
| 3 | -$8.84M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.78M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$4.28M |